The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Predictive Biomarkers-Global Market Insights and Sales Trends 2024
Synopsis
Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.
The global Predictive Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Predictive Biomarkers in various end use industries. The expanding demands from the Diagnostic Centers, Academic Research Institutes, CRO’S and Bio-Pharmaceutical Companies, are propelling Predictive Biomarkers market. Cancer, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Neurological Disorder segment is estimated at % CAGR for the next seven-year period.
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Predictive Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Predictive Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Predictive Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Predictive Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Predictive Biomarkers covered in this report include Siemens Healthcare, Roche Diagnostic, G.E. Healthcare, Abbott Laboratories, Qiagen and Johnson and Johnson, etc.
The global Predictive Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
Global Predictive Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Predictive Biomarkers market, Segment by Type:
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Global Predictive Biomarkers market, by Application
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Predictive Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.
The global Predictive Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Predictive Biomarkers in various end use industries. The expanding demands from the Diagnostic Centers, Academic Research Institutes, CRO’S and Bio-Pharmaceutical Companies, are propelling Predictive Biomarkers market. Cancer, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Neurological Disorder segment is estimated at % CAGR for the next seven-year period.
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Predictive Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Predictive Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Predictive Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Predictive Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Predictive Biomarkers covered in this report include Siemens Healthcare, Roche Diagnostic, G.E. Healthcare, Abbott Laboratories, Qiagen and Johnson and Johnson, etc.
The global Predictive Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
Global Predictive Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Predictive Biomarkers market, Segment by Type:
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Global Predictive Biomarkers market, by Application
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Predictive Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Predictive Biomarkers
1.1 Predictive Biomarkers Market Overview
1.1.1 Predictive Biomarkers Product Scope
1.1.2 Predictive Biomarkers Market Status and Outlook
1.2 Global Predictive Biomarkers Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Predictive Biomarkers Market Size by Region (2018-2029)
1.4 Global Predictive Biomarkers Historic Market Size by Region (2018-2023)
1.5 Global Predictive Biomarkers Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Predictive Biomarkers Market Size (2018-2029)
1.6.1 North America Predictive Biomarkers Market Size (2018-2029)
1.6.2 Europe Predictive Biomarkers Market Size (2018-2029)
1.6.3 Asia-Pacific Predictive Biomarkers Market Size (2018-2029)
1.6.4 Latin America Predictive Biomarkers Market Size (2018-2029)
1.6.5 Middle East & Africa Predictive Biomarkers Market Size (2018-2029)
2 Predictive Biomarkers Market by Type
2.1 Introduction
2.1.1 Cancer
2.1.2 Neurological Disorder
2.1.3 Cardiovascular Disorder
2.1.4 Immunological Disorder
2.1.5 Others
2.2 Global Predictive Biomarkers Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Predictive Biomarkers Historic Market Size by Type (2018-2023)
2.2.2 Global Predictive Biomarkers Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Predictive Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Predictive Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Predictive Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Predictive Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Predictive Biomarkers Revenue Breakdown by Type (2018-2029)
3 Predictive Biomarkers Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Centers
3.1.2 Academic Research Institutes
3.1.3 CRO’S
3.1.4 Bio-Pharmaceutical Companies
3.2 Global Predictive Biomarkers Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Predictive Biomarkers Historic Market Size by Application (2018-2023)
3.2.2 Global Predictive Biomarkers Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Predictive Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Predictive Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Predictive Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Predictive Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Predictive Biomarkers Revenue Breakdown by Application (2018-2029)
4 Predictive Biomarkers Competition Analysis by Players
4.1 Global Predictive Biomarkers Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Predictive Biomarkers as of 2022)
4.3 Date of Key Players Enter into Predictive Biomarkers Market
4.4 Global Top Players Predictive Biomarkers Headquarters and Area Served
4.5 Key Players Predictive Biomarkers Product Solution and Service
4.6 Competitive Status
4.6.1 Predictive Biomarkers Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens Healthcare
5.1.1 Siemens Healthcare Profile
5.1.2 Siemens Healthcare Main Business
5.1.3 Siemens Healthcare Predictive Biomarkers Products, Services and Solutions
5.1.4 Siemens Healthcare Predictive Biomarkers Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Healthcare Recent Developments
5.2 Roche Diagnostic
5.2.1 Roche Diagnostic Profile
5.2.2 Roche Diagnostic Main Business
5.2.3 Roche Diagnostic Predictive Biomarkers Products, Services and Solutions
5.2.4 Roche Diagnostic Predictive Biomarkers Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostic Recent Developments
5.3 G.E. Healthcare
5.3.1 G.E. Healthcare Profile
5.3.2 G.E. Healthcare Main Business
5.3.3 G.E. Healthcare Predictive Biomarkers Products, Services and Solutions
5.3.4 G.E. Healthcare Predictive Biomarkers Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Predictive Biomarkers Products, Services and Solutions
5.4.4 Abbott Laboratories Predictive Biomarkers Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Qiagen
5.5.1 Qiagen Profile
5.5.2 Qiagen Main Business
5.5.3 Qiagen Predictive Biomarkers Products, Services and Solutions
5.5.4 Qiagen Predictive Biomarkers Revenue (US$ Million) & (2018-2023)
5.5.5 Qiagen Recent Developments
5.6 Johnson and Johnson
5.6.1 Johnson and Johnson Profile
5.6.2 Johnson and Johnson Main Business
5.6.3 Johnson and Johnson Predictive Biomarkers Products, Services and Solutions
5.6.4 Johnson and Johnson Predictive Biomarkers Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson and Johnson Recent Developments
6 North America
6.1 North America Predictive Biomarkers Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Predictive Biomarkers Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Predictive Biomarkers Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Predictive Biomarkers Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Predictive Biomarkers Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Predictive Biomarkers Market Dynamics
11.1 Predictive Biomarkers Industry Trends
11.2 Predictive Biomarkers Market Drivers
11.3 Predictive Biomarkers Market Challenges
11.4 Predictive Biomarkers Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
